Welcome to our dedicated page for CIMG SEC filings (Ticker: IMG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CIMG Inc. (IMG), also referred to as C Inc., files a range of documents with the U.S. Securities and Exchange Commission that shed light on its digital health, cryptocurrency, computing power and capital markets activities. This SEC filings page brings those disclosures together and pairs them with AI-powered summaries to help readers interpret the key points in each report.
Recent Form 8-K current reports provide detailed information on several material events. One 8-K describes a Bitcoin Purchase Agreement entered into by a Singapore subsidiary to acquire 230 Bitcoin from Lordan Group Ltd., including pricing mechanics, funding from internal capital and the resulting increase in total Bitcoin holdings to 730. The same filing also outlines a China Merchants Bank IT Equipment Procurement Framework Contract, under which subsidiary Zhongyan Shangyue Technology Co., Ltd. agreed to supply computing power and server equipment, including CPU and GPU servers, with installation, warranty and maintenance obligations.
Other 8-Ks cover computing power product sales contracts via subsidiaries for high-performance computing servers and NVIDIA graphics cards, the shortlisting of Beijing Xinmiao Shidai Technology Development Co., Ltd. in a Guangzhou Bank server procurement tender, and the establishment of a Hong Kong subsidiary, Braincoin Limited, to expand a global computing power ecosystem. Additional filings discuss the company’s cryptocurrency and on-chain finance initiatives, such as the non-binding memorandum of understanding with iZUMi Finance to collaborate on the Upstarts Fund, an on-chain crypto fund for corporate digital asset deployment.
CIMG’s filings also address capital structure and listing matters. One 8-K details a 1-for-20 reverse stock split of common stock, including its effectiveness date and impact on issued and outstanding shares. Another 8-K describes stockholder approval to increase authorized common shares from 200,000,000 to 600,000,000, as well as the adoption of the C Inc. 2026 Equity Incentive Plan and ratification of the independent registered public accounting firm. A separate 8-K presents a pro forma balance sheet and explains how equity issuances and warrant exercises support the company’s belief that it has achieved compliance with Nasdaq Listing Rule 5550(b)(1) on shareholders’ equity.
Through this page, users can access CIMG’s 8-Ks, proxy materials and related exhibits, while AI-generated highlights call out important elements such as Bitcoin reserve transactions, computing power contracts, equity tokenization announcements and share-structure changes. This helps investors and researchers navigate complex regulatory language and focus on the disclosures most relevant to understanding IMG’s business model and capital markets profile.
CIMG Inc. reported that it received an additional delisting determination letter from Nasdaq on February 23, 2026. A Nasdaq Hearings Panel will treat the company’s failure to timely file its Form 10‑Q for the quarter ended December 31, 2025 as another basis for potentially removing its shares from The Nasdaq Capital Market during an existing monitoring period.
The company remains subject to a Mandatory Panel Monitor through November 14, 2026, meaning any new compliance failure can trigger a delisting determination. CIMG stated that the letter does not immediately affect the listing or trading of its common stock, which continues to trade under the symbol “IMG”, and that it is working diligently to complete and file the delayed Form 10‑Q as soon as practicable.
CIMG Inc. has changed its independent auditor. On February 18, 2026, the audit committee dismissed Assentsure PAC as the company’s independent registered public accounting firm and engaged ST & Partners PLT for the fiscal year ending September 30, 2026, including reviews of specified interim periods.
The company states that Assentsure’s reports for the years ended September 30, 2025 and 2024 contained no adverse opinions or disclaimers and were not qualified. It also reports no disagreements or reportable events with Assentsure over those fiscal years or the subsequent interim period, and has filed Assentsure’s confirmation letter as an exhibit.
CIMG Inc. notified the SEC that it cannot timely file its Form 10-Q for the three months ended
The notice states the company added the homology of medicine and food series and the computing power series to its revenue streams and continued sales of its Maca series, and anticipates revenue increased significantly for the quarter versus the prior-year period. It also discloses that the company acquired bitcoins during the quarter, and anticipates total assets increased significantly compared to
CIMG Inc. regained compliance with Nasdaq’s Minimum Bid Price Requirement after receiving confirmation from the Nasdaq Listing Qualifications Hearings office. The company remains subject to a Hearing Panel exception related to timely periodic filings and will be monitored for one year from February 10, 2026.
If CIMG falls out of compliance with any Nasdaq listing rule during this monitoring period, staff must issue a delisting determination without an additional cure period, though the company could request a new hearing. CIMG also released fiscal year 2025 results, highlighting significant revenue growth and a continued reduction in net loss, driven by a strategic focus on AI computing infrastructure, digital health and a cryptocurrency-focused strategy that may include increasing Bitcoin holdings over time.
CIMG Inc. entered into a private placement agreement with non-U.S. investors for up to
The notes carry
Both note conversion and warrant exercise are conditioned on CIMG obtaining required shareholder approval under Nasdaq listing rules. The warrant coverage for each tranche is based on the principal amount of notes divided by the Nasdaq “Minimum Price” at the relevant closing.
CIMG Inc. files its annual report describing a major shift from U.S. specialty coffee into Asian health and wellness products and AI-enabled “Computing Power Product” hardware. The Homology of Medicine and Food Series generated
The company remains unprofitable, with a net loss of
CIMG Inc. reported that Nasdaq is considering an additional basis to delist its common stock because the company has not timely filed its Annual Report on Form 10-K for the fiscal year ended September 30, 2025. Nasdaq’s Hearings Panel had already placed the company under a Mandatory Panel Monitor on December 4, 2025, which runs until November 14, 2026 and requires a delisting determination if the company fails to maintain compliance during this period.
The new Nasdaq letter does not immediately affect the listing or trading of CIMG’s shares on The Nasdaq Capital Market, but it highlights the risk that the securities may ultimately be delisted if the filing and related compliance issues are not resolved.
CIMG Inc. is informing stockholders that a written majority holding about 67.4% of voting power has approved three major corporate actions without a meeting. First, the Board may implement a reverse stock split at a ratio between 1‑for‑2 and 1‑for‑50 within twelve months of December 24, 2025, mainly to support a higher share price and potential exchange listing, with noted risks around liquidity and market value. Second, authorized common shares will rise from 600,000,000 to 2,000,000,000, giving the Board wide flexibility to issue additional equity. Third, the company may issue units, each with one share and one warrant, for up to $850,000,000 in proceeds at a price below the Nasdaq Minimum Price; depending on final pricing, this financing could involve issuing 20% or more of post‑transaction common stock, with an illustrative case showing roughly 1.97 billion new shares, heavily diluting existing holders.
CIMG Inc. reported that its subsidiaries entered into initial computing power-related commercial contracts during the fourth quarter of 2025. These multiple sales contracts and framework agreements have an aggregate contract value of approximately $124 million. The agreements cover computing power services and are described as initial contracts in this area for the company.
The contracts are subject to customary conditions, including customers’ order quantities, inspections, and acceptance, so actual revenue will depend on how these conditions are satisfied over time.
CIMG Inc. reported two major transactions and several new contracts. Through its Singapore subsidiary, the company agreed to buy and has completed the purchase of 230 Bitcoin under a Bitcoin Purchase Agreement with Lordan Group Ltd. The aggregate purchase price was approximately USD 24.61 million, funded with internal capital, bringing CIMG’s total Bitcoin holdings to 730 BTC.
Separately, its subsidiary Zhongyan Shangyue signed a China Merchants Bank IT Equipment Procurement Framework Contract with a total agreement value of about RMB 752.2 million (approximately USD 106.5 million), covering CPU and GPU servers plus installation, a 60‑month warranty and maintenance. The company also highlighted two additional computing power product sales contracts via subsidiaries with an aggregate value of approximately USD 1.78 million.